OGD 206Alternative Names: OGD206
Latest Information Update: 28 Jun 2016
At a glance
- Originator OGD2 Pharma
- Class Imaging agents
- Mechanism of Action Image enhancers
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Cancer
Most Recent Events
- 28 Jun 2016 Early research in Cancer (Diagnosis) in France (unspecified route)